Charles Schwab Investment Management Inc Spectrum Pharmaceuticals Inc Transaction History

Charles Schwab Investment Management Inc

$515 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.43 - $1.56 $35,555 - $128,991	82,687 New	82,687 $36,000
Q2 2022 Aug 15, 2022	SELL	$0.7 - $1.4 $302,839 - $605,679	-432,628 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$0.63 - $1.59 $14,317 - $36,134	22,726 Added 5.54%	432,628 $559,000
Q4 2021 Feb 11, 2022	BUY	$1.27 - $2.42 $224 - $428	177 Added 0.04%	409,902 $521,000
Q3 2021 Nov 16, 2021	SELL	$2.15 - $3.82 $1.47 Million - $2.62 Million	-685,864 Reduced 62.6%	409,725 $893,000
Q2 2021 Aug 16, 2021	BUY	$2.89 - $4.45 $309,860 - $477,120	107,218 Added 10.85%	1,095,589 $4.11 Million
Q1 2021 May 17, 2021	BUY	$2.9 - $4.09 $52,922 - $74,638	18,249 Added 1.88%	988,371 $3.22 Million
Q4 2020 Feb 16, 2021	BUY	$3.38 - $5.14 $17,369 - $26,414	5,139 Added 0.53%	970,122 $3.31 Million
Q3 2020 Nov 13, 2020	BUY	$2.99 - $4.9 $623,011 - $1.02 Million	208,365 Added 27.54%	964,983 $3.94 Million
Q2 2020 Aug 14, 2020	BUY	$2.11 - $3.38 $127,910 - $204,898	60,621 Added 8.71%	756,618 $2.56 Million
Q1 2020 May 15, 2020	BUY	$1.83 - $3.45 $11,644 - $21,952	6,363 Added 0.92%	695,997 $1.62 Million
Q4 2019 Feb 07, 2020	BUY	$3.5 - $10.35 $50,603 - $149,640	14,458 Added 2.14%	689,634 $2.51 Million
Q3 2019 Nov 08, 2019	BUY	$7.03 - $9.7 $274,191 - $378,329	39,003 Added 6.13%	675,176 $5.6 Million
Q2 2019 Aug 09, 2019	BUY	$7.36 - $11.26 $273,593 - $418,567	37,173 Added 6.21%	636,173 $5.48 Million
Q1 2019 May 14, 2019	BUY	$9.08 - $11.84 $381,232 - $497,114	41,986 Added 7.54%	599,000 $6.4 Million
Q4 2018 Feb 14, 2019	SELL	$6.39 - $16.99 $271,856 - $722,822	-42,544 Reduced 7.1%	557,014 $4.87 Million
Q3 2018 Nov 13, 2018	BUY	$16.52 - $24.82 $562,985 - $845,840	34,079 Added 6.03%	599,558 $10.1 Million
Q2 2018 Aug 08, 2018	BUY	$14.31 - $21.75 $1.25 Million - $1.89 Million	87,075 Added 18.2%	565,479 $11.9 Million
Q1 2018 May 07, 2018	BUY	$16.09 - $23.07 $321,059 - $460,338	19,954 Added 4.35%	478,404 $7.7 Million
Q4 2017 Jan 17, 2018	SELL	$13.36 - $20.73 $634,052 - $983,825	-47,459 Reduced 9.38%	458,450 $8.69 Million
Q3 2017 Nov 13, 2017	BUY	$8.75 - $14.07 $4.43 Million - $7.12 Million	505,909	505,909 $7.12 Million

Others Institutions Holding SPPI

# of Institutions

Shares Held

115K

Call Options Held

Put Options Held

Tekla Capital Management LLC

115K
Shares

$0
0.0% of portfolio

View Full List

About SPECTRUM PHARMACEUTICALS INC

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

More about SPPI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account